title: HIV therapy, hepatitis C virus infection, antibiotics and obesity, a mitochondria killer mix?
authors.forename: Hélène C F
authors.initials: HC
authors.lastname: Côté
authors.forename: Zabrina L
authors.initials: ZL
authors.lastname: Brumme
authors.forename: Jennifer W
authors.initials: JW
authors.lastname: Chan
authors.forename: Silvia
authors.initials: S
authors.lastname: Guillemi
authors.forename: Julio S G
authors.initials: JS
authors.lastname: Montaner
authors.forename: P Richard
authors.initials: PR
authors.lastname: Harrigan
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D016174:Hepacivirus; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000187:drug effects; D009765:Obesity / Q000150:complications; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D018894:Reverse Transcriptase Inhibitors